178 related articles for article (PubMed ID: 11509603)
1. The recognition of HLA-B27 by human CD4(+) T lymphocytes.
Boyle LH; Goodall JC; Opat SS; Gaston JS
J Immunol; 2001 Sep; 167(5):2619-24. PubMed ID: 11509603
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
Boyle LH; Goodall JC; Gaston JS
Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184
[TBL] [Abstract][Full Text] [Related]
3. Breaking the rules: the unconventional recognition of HLA-B27 by CD4+ T lymphocytes as an insight into the pathogenesis of the spondyloarthropathies.
Boyle LH; Hill Gaston JS
Rheumatology (Oxford); 2003 Mar; 42(3):404-12. PubMed ID: 12626789
[TBL] [Abstract][Full Text] [Related]
4. The recognition of abnormal forms of HLA-B27 by CD4+ T cells.
Boyle LH; Goodall JC; Gaston JS
Curr Mol Med; 2004 Feb; 4(1):51-8. PubMed ID: 15011959
[TBL] [Abstract][Full Text] [Related]
5. HLA-B27 misfolding and spondyloarthropathies.
Colbert RA; DeLay ML; Layh-Schmitt G; Sowders DP
Adv Exp Med Biol; 2009; 649():217-34. PubMed ID: 19731632
[TBL] [Abstract][Full Text] [Related]
6. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
Kollnberger S; Bird LA; Roddis M; Hacquard-Bouder C; Kubagawa H; Bodmer HC; Breban M; McMichael AJ; Bowness P
J Immunol; 2004 Aug; 173(3):1699-710. PubMed ID: 15265899
[TBL] [Abstract][Full Text] [Related]
7. The immunobiology of HLA-B27: variations on a theme.
Colbert RA
Curr Mol Med; 2004 Feb; 4(1):21-30. PubMed ID: 15011956
[TBL] [Abstract][Full Text] [Related]
8. HLA-B27 and pathogenesis of spondyloarthropathies.
Turner MJ; Colbert RA
Curr Opin Rheumatol; 2002 Jul; 14(4):367-72. PubMed ID: 12118169
[TBL] [Abstract][Full Text] [Related]
9. Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.
Ridley A; Hatano H; Wong-Baeza I; Shaw J; Matthews KK; Al-Mossawi H; Ladell K; Price DA; Bowness P; Kollnberger S
Arthritis Rheumatol; 2016 Apr; 68(4):901-14. PubMed ID: 26841353
[TBL] [Abstract][Full Text] [Related]
10. Fully functional HLA B27-restricted CD4+ as well as CD8+ T cell responses in TCR transgenic mice.
Roddis M; Carter RW; Sun MY; Weissensteiner T; McMichael AJ; Bowness P; Bodmer HC
J Immunol; 2004 Jan; 172(1):155-61. PubMed ID: 14688321
[TBL] [Abstract][Full Text] [Related]
11. Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27.
Hacquard-Bouder C; Chimenti MS; Giquel B; Donnadieu E; Fert I; Schmitt A; André C; Breban M
Arthritis Rheum; 2007 May; 56(5):1478-89. PubMed ID: 17469106
[TBL] [Abstract][Full Text] [Related]
12. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.
Qian BF; Tonkonogy SL; Balfour Sartor R
Immunology; 2006 Mar; 117(3):319-28. PubMed ID: 16476051
[TBL] [Abstract][Full Text] [Related]
13. Animal models of HLA-B27-associated diseases.
Breban M; Hacquard-Bouder C; Falgarone G
Curr Mol Med; 2004 Feb; 4(1):31-40. PubMed ID: 15011957
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
Khare SD; Luthra HS; David CS
Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy.
Kuon W; Kuhne M; Busch DH; Atagunduz P; Seipel M; Wu P; Morawietz L; Fernahl G; Appel H; Weiss EH; Krenn V; Sieper J
J Immunol; 2004 Oct; 173(8):4859-66. PubMed ID: 15470026
[TBL] [Abstract][Full Text] [Related]
16. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.
Bowness P; Ridley A; Shaw J; Chan AT; Wong-Baeza I; Fleming M; Cummings F; McMichael A; Kollnberger S
J Immunol; 2011 Feb; 186(4):2672-80. PubMed ID: 21248258
[TBL] [Abstract][Full Text] [Related]
17. HLA-B27 transgenic rats model.
Breban M
Ann Med Interne (Paris); 1998 Apr; 149(3):139-41. PubMed ID: 11490535
[TBL] [Abstract][Full Text] [Related]
18. Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.
Chen L; Ridley A; Hammitzsch A; Al-Mossawi MH; Bunting H; Georgiadis D; Chan A; Kollnberger S; Bowness P
Ann Rheum Dis; 2016 May; 75(5):916-23. PubMed ID: 26130142
[TBL] [Abstract][Full Text] [Related]
19. The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.
Cauli A; Shaw J; Giles J; Hatano H; Rysnik O; Payeli S; McHugh K; Dessole G; Porru G; Desogus E; Fiedler S; Hölper S; Carette A; Blanco-Gelaz MA; Vacca A; Piga M; Ibba V; Garau P; La Nasa G; López-Larrea C; Mathieu A; Renner C; Bowness P; Kollnberger S
Rheumatology (Oxford); 2013 Nov; 52(11):1952-62. PubMed ID: 23804219
[TBL] [Abstract][Full Text] [Related]
20. HLA B27 in health and disease: a double-edged sword?
Bowness P
Rheumatology (Oxford); 2002 Aug; 41(8):857-68. PubMed ID: 12154202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
